Mounjaro contains tirzepatide, a once-weekly medicine that acts on GIP and GLP-1 receptors. Tirzepatide dosing is designed to increase gradually rather than starting at a high dose immediately.

The reason for this stepwise approach is mainly tolerability. Gastrointestinal side effects such as nausea, diarrhea, vomiting and constipation are more common when treatment begins or when the dose is increased.

What Is the Usual Starting Dose of Mounjaro?

The labelled starting dose of Mounjaro is 2.5 mg once weekly for 4 weeks. This starting dose is intended for treatment initiation and is not considered a maintenance dose for glycemic control.

After the initial 4 weeks, the labelled schedule generally increases to 5 mg once weekly. Further increases may be considered in 2.5 mg increments after at least 4 weeks on the current dose, depending on treatment response and tolerability.

How Does Tirzepatide Dose Escalation Work?

According to the labelled dosing framework, dose increases are made in 2.5 mg steps and only after at least 4 weeks on the current dose.

What Is the Maximum Mounjaro Dose?

The maximum labelled Mounjaro dose for adults is 15 mg once weekly.

That does not mean every patient should reach 15 mg. Some people may have an adequate response at a lower maintenance dose, while others may not tolerate further escalation.

Why Does Mounjaro Start at 2.5 mg?

The 2.5 mg starting phase allows the body to adapt to tirzepatide’s effects on appetite, digestion and glucose regulation. Starting gradually is particularly relevant because gastrointestinal symptoms tend to occur most often during treatment initiation and dose escalation.

This is also why patients should not compare themselves with someone who is already taking a higher dose. A dose that is appropriate after several months of treatment may not be appropriate for a new patient.

Is 2.5 mg a Maintenance Dose?

Under the standard Mounjaro prescribing framework, 2.5 mg is an initiation dose rather than a maintenance dose for glycemic control. The next labelled step after four weeks is generally 5 mg once weekly.

Individual treatment decisions can still differ because clinicians must consider the patient’s medical history, response and tolerability.

Do You Have to Increase the Dose Every 4 Weeks?

No. Four weeks is the minimum interval used in the labelled escalation framework before a further increase is considered. It does not mean a dose must automatically be increased every four weeks.

If a patient is responding well or experiencing side effects, a clinician may decide that increasing the dose is not appropriate at that time.

What Mounjaro Strengths Are Registered in Thailand?

Thailand’s FDA drug-information database lists Mounjaro products containing tirzepatide in the following strengths:

• 2.5 mg;
• 5 mg;
• 7.5 mg;
• 10 mg;
• 12.5 mg;
• 15 mg.

The Thai FDA database also lists Mounjaro KwikPen presentations in these strengths. Registration does not guarantee real-time availability, and the appropriate strength depends on the individual treatment plan.

Learn more about Mounjaro (Tirzepatide) in Thailand →

Can You Start Tirzepatide at 5 mg or a Higher Dose?

The standard labelled Mounjaro schedule begins at 2.5 mg once weekly. Starting at a higher dose without medical assessment may increase the risk of gastrointestinal side effects and is not the standard initiation schedule.

Previous treatment with another GLP-1 medicine does not automatically determine the correct tirzepatide starting dose.

Can Semaglutide Doses Be Converted Directly to Tirzepatide?

No simple milligram-to-milligram conversion should be assumed between semaglutide and tirzepatide. They are different medicines with different receptor activity, formulations and dosing schedules.

A patient switching from Ozempic, Wegovy or another GLP-1 treatment should have the current product, current dose, last dose date, side effects and reason for switching reviewed by a clinician.

Read: Mounjaro vs Ozempic — What’s the Difference? →

How Do Side Effects Affect Dose Decisions?

Nausea, diarrhea, vomiting, constipation and abdominal discomfort are among the most common tirzepatide side effects. These symptoms are often more noticeable during dose escalation.

If symptoms are significant, persistent or worsening, the answer is not automatically to continue increasing the dose. A medical review can help determine whether the current dose should be maintained, adjusted or whether another treatment approach is more appropriate.

Read: Tirzepatide Side Effects — What Patients Should Know →

Does a Higher Dose Produce More Weight Loss?

Clinical trials have shown greater average weight reduction with higher tirzepatide doses in study populations. However, study averages do not mean an individual patient needs the maximum dose to benefit.

Weight response varies considerably. The best maintenance dose is therefore not simply the highest available dose but the dose that provides an appropriate balance of benefit and tolerability under medical supervision.

What If You Miss a Dose?

Missed-dose instructions depend on the specific medicine and product information. Patients should follow the instructions supplied with their prescribed Mounjaro product or contact their prescriber or pharmacist if unsure.

Do not take extra medication to compensate for a missed dose unless specifically instructed to do so by a qualified healthcare professional.

Already Using Tirzepatide?

If you are already taking Mounjaro or tirzepatide, a treatment review should include more than just the dose number.

The medical team may need to know:

• your current dose;
• your last injection date;
• how long you have been on the current dose;
• how long you have used tirzepatide overall;
• your treatment response;
• any side effects;
• other medications;
• relevant medical conditions.

Already Using Treatment → Start Treatment Review

Frequently Asked Questions

What is the starting dose of Mounjaro?

The standard labelled starting dose is 2.5 mg once weekly for four weeks, followed by 5 mg once weekly under the prescribing framework.

How quickly can Mounjaro be increased?

The labelled schedule uses at least four weeks at the current dose before a further 2.5 mg increase is considered.

What is the highest Mounjaro dose?

The maximum labelled adult dose is 15 mg once weekly.

Does everyone need to reach 15 mg?

No. The appropriate maintenance dose depends on treatment response, tolerability and medical assessment.

Can I increase the dose if my appetite returns?

Appetite alone should not be used to make an unsupervised dose change. Treatment response, side effects and other clinical factors should be reviewed first.

Can I use the same dose as another person?

No. Tirzepatide dosing should be based on the individual patient’s treatment history and medical assessment rather than another person’s plan.

Final Thoughts

Mounjaro dosing follows a gradual escalation framework designed to balance treatment effect with tolerability. The standard labelled schedule starts at 2.5 mg once weekly, progresses to 5 mg after four weeks, and allows further 2.5 mg increases after at least four weeks at the current dose when clinically appropriate.

The most important point is that dose escalation is not a race to 15 mg. The right maintenance dose is the one that fits the individual patient’s response, side effects and medical circumstances.

Sources

Key references used for this article include official Mounjaro/tirzepatide prescribing information and Thailand FDA’s National Drug Information database, which lists registered Mounjaro and Mounjaro KwikPen strengths in Thailand.

Medical Disclaimer